An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, Aaron M, Bratman, Scott V, To, Jacqueline, Wynne, Jacob F, Eclov, Neville C W, Modlin, Leslie A, Liu, Chih Long, Neal, Joel W +6 more·2014·Nature Medicine
DOI 10.1038/nm.3519
Cited by (1,002)
Items 601–700 of 1,002
- Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patientsJose Espejo Valle-Inclán, Christina Stangl, Anouk C. de Jong, Lisanne F. van Dessel, Markus J. van Roosmalen, Jean Helmijr, Ivo Renkens, Roel Janssen, Sam de Blank, Chris J. de Witte et al. · 2021 · Genome Medicine
- Accurate detection of circulating tumor DNA using nanopore consensus sequencingAlessio Marcozzi, Myrthe Jager, Martin Elferink, Roy Straver, Joost H. van Ginkel, Boris Peltenburg, Li‐Ting Chen, Ivo Renkens, Joyce van Kuik, Chris H.J. Terhaard et al. · 2021 · npj Genomic Medicine
- EGFR T790M: revealing the secrets of a gatekeeperBrian Ko, Daniel Paucar, Balázs Halmos · 2017 · Lung Cancer Targets and Therapy
- Blood-based biomarkers in lung cancer: prognosis and treatment decisionsMeng Xu‐Welliver, David Paul Carbone · 2017 · Translational Lung Cancer Research
- Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNAAmin Aalipour, Jonathan C. Dudley, Seung-min Park, Surya Murty, Jacob J. Chabon, Evan A. Boyle, Maximilian Diehn, Sanjiv Sam Gambhir · 2017 · Clinical Chemistry
- Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and ChallengesAndrew E. Rodda, Bradyn J. Parker, Andrew G Spencer, Simon R. Corrie · 2018 · ACS Sensors
- Thermodynamics and kinetics guided probe design for uniformly sensitive and specific DNA hybridization without optimizationXin Chen, Na Liu, Liquan Liu, Wei Chen, Na Chen, Meng Lin, Jia-Ju Xu, Xing Zhou, Hongbo Wang, Mei-Ping Zhao et al. · 2019 · Nature Communications
- Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid TumorsSeyed Mohammad Kazem Aghamir, Ramin Heshmat, Mehdi Ebrahimi, Fatemeh Khatami · 2020 · Epigenetics Insights
- Ultra-sensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinomaAshwini Shanmugam, A. Hariharan, R. Hasina, J. Nair, S. Katragadda, Sivaraj Irusappan, A. Ravichandran, V. Veeramachaneni, Radhakrishna Bettadapura, Muddasir Bhati et al. · 2020 · Cancer
- High sensitivity automated multiplexed immunoassays using photonic crystal enhanced fluorescence microfluidic systemYafang Tan, Tiantian Tang, Haisheng Xu, Chenqi Zhu, Brian T. Cunningham · 2015 · Biosensors and Bioelectronics
- Liquid biopsies for residual disease and recurrenceJonathan C. M. Wan, Tariq I. Mughal, Pedram Razavi, Sarah‐Jane Dawson, Esther Louise Moss, Ramaswamy Govindan, Iain Beehuat Tan, Yoon Sim Yap, William Allen Robinson, Clive Dylan Morris et al. · 2021 · Med
- Polyanions in Coagulation and Thrombosis: Focus on Polyphosphate and Neutrophils Extracellular TrapsChandini Rangaswamy, Hanna Englert, Carsten Deppermann, Thomas Renné · 2020 · Thrombosis and Haemostasis
- Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancerArianna Marinello, Marco Tagliamento, Arianna Pagliaro, Nicole Conci, Eugenia Cella, Damien Vasseur, Jordi Remón, Antonin Lévy, Filippo Gustavo Dall’Olio, Benjamin Besse · 2024 · Cancer Treatment Reviews
- Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic DevelopmentGennady Margolin, Hanna M. Petrykowska, Nader Jameel, Daphne W. Bell, Alice Young, Laura L. Elnitski · 2016 · Journal of Molecular Diagnostics
- The Role of Next‐Generation Sequencing in Enabling Personalized Oncology TherapyCA Cummings, Eric J Peters, Ludovic Lacroix, Fabrice André, MR Lackner · 2016 · Clinical and Translational Science
- Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?Luc Cabel, Charlotte Proudhon, Pascale Mariani, Dimitri Tzanis, Guillaume Beinse, Ivan Bièche, Jean‐Yves Pierga, François‐Clément Bidard · 2017 · European Journal of Surgical Oncology
- Cell-Free DNA in Oncology: Gearing up for ClinicBryan C. Ulrich, Cloud Peter Paweletz · 2017 · Annals of Laboratory Medicine
- Circulating Tumor DNA for Early Cancer DetectionClare Fiala, Vathany Kulasingam, Eleftherios P. Diamandis · 2018 · The Journal of Applied Laboratory Medicine
- Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) PatientsFeng Li, Wei Fang, Wei-Lun Huang, Chien‐Chung Lin, Liang Li, Macy Shen, Qingxiang Yan, Wei Liao, David Chia, Michael Kai Tu et al. · 2020 · Cancers
- Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA SequencingYunpeng Yang, Jie Huang, Tao Wang, Jianya Zhou, Jing Zheng, Jifeng Feng, Wu Zhuang, Jianhua Chen, Jun Zhao, Wei Zhong et al. · 2021 · Journal of Thoracic Oncology
- Preclinical models and technologies to advance nanovaccine developmentCarina Peres, Ana I. Matos, Liane I.F. Moura, Rita C. Acúrcio, Bárbara Carreira, Sabina Pozzi, Daniella Vaskovich‐Koubi, Ron Kleiner, Ronit Satchi‐Fainaro, Helena F. Florindo · 2021 · Advanced Drug Delivery Reviews
- Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification poolsJessica Garcia, Nick Kamps‐Hughes, Florence Geiguer, S. Couraud, Brice A. J. Sarver, Lea Francoise Payen, Cristian Ionescu‐Zanetti · 2021 · Scientific Reports
- Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural EffusionsMaria Alba Sorolla, Anabel Sorolla, Eva Parisi, Antonieta Salud, José Manuel Porcel · 2021 · Cancers
- Early diagnosis of lung cancer using magnetic nanoparticles-integrated systemsAyushi Rastogi, Kanchan Yadav, Archana Mishra, Manu Smriti Singh, Shilpi Chaudhary, Rajiv Manohar, Avanish Singh Parmar · 2022 · Nanotechnology Reviews
- Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung CancerPeng‐Peng Kuang, Ning Li, Zui Liu, Tianyu Sun, Shu-Quan Wang, Jia Hu, Wei Ou, Si-Yu Wang · 2021 · Frontiers in Oncology
- A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary NodulesQuanxing Liu, Dong Zhou, Tiancheng Han, Xiao Lu, Bing Hou, Manyuan Li, Guixue Yang, Qingyuan Li, Zhihua Pei, Yuanyuan Hong et al. · 2021 · Advanced Science
- Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic CancerKazunori Watanabe, Toru Nakamura, Yasutoshi Kimura, Masayo Motoya, Shigeyuki Kojima, Tomotaka Kuraya, Takeshi Murakami, Tsukasa Kaneko, Yoshihito Shinohara, Yosuke Kitayama et al. · 2022 · International Journal of Molecular Sciences
- Advances in Liquid Biopsy Technology and Implications for Pancreatic CancerAlexander Grenander Raufi, Michael S. May, Matthew James Hadfield, Attila A. Seyhan, Wafik S. El‐Deiry · 2023 · International Journal of Molecular Sciences
- The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercializationAbel Jacobus Bronkhorst, Stefan Holdenrieder · 2023 · Medizinische Genetik
- Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acidsJean M. Lewis, Daniel P. Heineck, Michael J. Heller · 2015 · Expert Review of Molecular Diagnostics
- Fluorogenic Templated Reaction Cascades for RNA DetectionWillem A. Velema, Eric T. Kool · 2017 · Journal of the American Chemical Society
- Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patientsAtsushi Mitsuhashi, Yusuke Okuma · 2018 · Clinical & Translational Oncology
- Biomarkers in Immunotherapy-Based Precision Treatments of Digestive System TumorsZhu Zeng, Biao Yang, Zhengyin Liao · 2021 · Frontiers in Oncology
- Molecular testing in stage I–III non-small cell lung cancer: Approaches and challengesCharu Aggarwal, Lukas Bubendorf, Wendy A. Cooper, Peter Bela Illei, Paula Borralho, Boon‐Hean Ong, Ming‐Sound Tsao, Yasushi Yatabe, Keith M. Kerr · 2021 · Lung Cancer
- The Role of Circulating Biomarkers in Lung CancerSayuri Herath, Habib Sadeghirad, Payar Radfar, Rahul Ladwa, Majid Ebrahimi Warkiani, Kenneth John O'Byrne, Arutha Kulasinghe · 2022 · Frontiers in Oncology
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung CancerViswam S. Nair, Angela Bik‐Yu Hui, Jacob J. Chabon, Mohammad Shahrokh Esfahani, Henning Stehr, Barzin Y. Nabet, Li Zhou, Aadel A. Chaudhuri, Jalen Anthony Benson, Kelsey Ayers et al. · 2022 · Cancer Research
- Biomarkers for early diagnosis of pancreatic cancerJenkinson, Claire, Earl, Julie, Ghaneh, Paula, Halloran, Christopher, Carrato, Alfredo, Greenhalf, William, Neoptolemos, John, Costello, Eithne · 2015 · Expert Review of Gastroenterology & Hepatology
- A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric SarcomasShah, Avanthi Tayi, Azad, Tej D., Breese, Marcus R., Chabon, Jacob J., Hamilton, Emily G., Straessler, Krystal, Kurtz, David M., Leung, Stanley G., Spillinger, Aviv, Liu, Heng-Yi et al. · 2021 · Molecular Cancer Therapeutics
- Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysisRan Zhong, Rui Gao, Wenhai Fu, Caichen Li, Zhenyu Huo, Yuewen Gao, Yi Lu, Feng Li, Fan Ge, Hengjia Tu et al. · 2023 · BMC Medicine
- BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challengesL. Collet, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolas Chopin, Olivia Le Saux, Isabelle Laure Ray-Coquard · 2024 · Frontiers in Oncology
- Liquid biopsies across the cancer care continuumBlair V. Landon, Akshaya Vijaya Annapragada, Noushin Niknafs, Victor E. Velculescu, Valsamo Anagnostou · 2025 · Nature Medicine
- Comparison of Genetic and Epigenetic Alterations of Primary Tumors and Matched Plasma Samples in Patients with Colorectal CancerElisa Danese, Anna Maria Minicozzi, Marco Benati, Martina Montagnana, Elisa Paviati, Gian Luca Salvagno, Gabriel Lima-Oliveira, Milena Gusella, Felice Pasini, Giuseppe Lippi et al. · 2015 · PLoS ONE
- The current status of the clinical utility of liquid biopsies in cancerAnson E. Snow, Denaly Chen, Julie E. Lang · 2019 · Expert Review of Molecular Diagnostics
- Clonal Hematopoiesis in Late-Stage Non–Small-Cell Lung Cancer and Its Impact on Targeted Panel Next-Generation SequencingStephanie J. Yaung, Frederike Fuhlbrück, Maureen Peterson, Wei Zou, John F. Palma, Namrata S. Patil, Yuqiu Jiang · 2020 · JCO Precision Oncology
- Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomasBraig, David, Becherer, Caroline, Bickert, Christiane, Braig, Moritz, Claus, Rainer, Eisenhardt, Anja E., Heinz, Juergen, Scholber, Jutta, Herget, Georg W., Bronsert, Peter et al. · 2019 · International Journal of Cancer
- The promises and challenges of early non‐small cell lung cancer detection: patient perceptions, low‐dose CT screening, bronchoscopy and biomarkersLukas Kalinke, Ricky M. Thakrar, Sam M. Janes · 2020 · Molecular Oncology
- The Role of Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-AnalysisHaowei Wang, Fei Zhou, Meng Qiao, Xuefei Li, Chao Zhao, Lei Cheng, Xiaoxia Chen, Caicun Zhou · 2021 · Frontiers in Oncology
- Liquid Biopsies in Lung CancerMarcel Kemper, Carolin Krekeler, Kerstin Menck, Georg Lenz, Georg Evers, Arik Bernard Schulze, Annalen Bleckmann · 2023 · Cancers
- Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAJan‐Michel Heger, Julia Mattlener, Jessica Schneider, Philipp Gödel, Noëlle Sieg, Fabian Ullrich, Richard I. Lewis, Teodora Bucaciuc Mracica, Roland F. Schwarz, Daniel F. Ruess et al. · 2023 · Blood
- Defining molecular risk in ALK+ NSCLCPetros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger · 2019 · Oncotarget
- Assessment of circulating copy number variant detection for cancer screeningBhuvan Molparia, Eshaan Nichani, Ali Torkamani · 2017 · PLoS ONE
- Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasmaSuman Verma, Mathew W. Moore, Rebecca Ringler, Abhisek Ghosal, Kyle C. Horvath, Theodore Naef, Sheri Anvari, Philip D. Cotter, Shelly R. Gunn · 2020 · BMC Cancer
- Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerationsDaniel Andersson, Helena Kristiansson, Mikael Kubista, Anders Ståhlberg · 2021 · Expert Review of Molecular Diagnostics
- Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencingEiji Iwama, Kazuko Sakai, Koichi Azuma, Daijiro Harada, Kaname Nosaki, Katsuyuki Hotta, Makoto Nishio, Takayasu Kurata, Tatsuro Fukuhara, Hiroaki Akamatsu et al. · 2018 · Cancer Science
- Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancerKentaro Tanaka, Kenji Chamoto, Sho Saeki, Ryusuke Hatae, Yuki Ikematsu, Kazuko Sakai, Nobuhisa Ando, Kazuhiro Sonomura, Shinsuke Kojima, Masanori Taketsuna et al. · 2022 · Science Translational Medicine
- Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal CancerJiaolin Zhou, Lianpeng Chang, Yanfang Guan, Ling Yang, Xuefeng Xia, Liqiang Cui, Xin Yi, Guole Lin · 2016 · PLoS ONE
- Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasiasBernhard Gerber, Martina Manzoni, Valeria Spina, Alessio Bruscaggin, Marta Lionetti, Sonia Fabris, Marzia Barbieri, Gabriella Ciceri, Alessandra Pompa, Gabriela Forestieri et al. · 2018 · Haematologica
- From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world settingSteven P. Rowe, Brandon S. Luber, Monique Makell, Patricia Brothers, JoAnn Santmyer, Megan Davis Schollenberger, Hannah Quinn, Daniel L. Edelstein, Frederick Scheetz Jones, Karen B. Bleich et al. · 2018 · Molecular Oncology
- Circulating Tumor DNA and Hepatocellular CarcinomaJu Dong Yang, MC Liu, John B. Kisiel · 2019 · Seminars in Liver Disease
- One-step enzyme-free detection of the miRNA let-7a via twin-stage signal amplificationJiamei Pu, Mingbin Liu, Hongbo Li, Zhigang Liao, Weihua Zhao, Suqin Wang, Yun Zhang, Ru‐Qin Yu · 2021 · Talanta
- Exploring genetic alterations in circulating tumor DNA from cerebrospinal fluid of pediatric medulloblastomaYanling Sun, Miao Li, Siqi Ren, Yan Liu, Jin Zhang, Shuting Li, Wenchao Gao, Xiaojun Gong, Jingjing Liu, Yuan Wang et al. · 2021 · Scientific Reports
- Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical SignificanceSheng‐Han Wang, Shiou‐Hwei Yeh, Pei‐Jer Chen · 2021 · Cancers
- Radiogenomic Analysis of Locally Advanced Lung Cancer Based on CT Imaging and Intratreatment Changes in Cell-Free DNAKyle Jon Lafata, Michael Nino Corradetti, Junheng Gao, Corbin D. Jacobs, Jingxi Weng, Yushi Chang, Chunhao Wang, Ace Joseph Hatch, Eric P. Xanthopoulos, Greg Jones et al. · 2021 · Radiology Imaging Cancer
- Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosisShuo Li, Zorawar Singh Noor, Weihua Zeng, Mary L. Stackpole, Xiaohui Ni, Yonggang Zhou, Zuyang Yuan, Wing Hung Wong, Vatche Garen Agopian, Steven M. Dubinett et al. · 2021 · Nature Communications
- Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European PerspectiveUmberto Malapelle, Marcello Tiseo, Ana P. Vivancos, Joshua R. Kapp, María José Serrano, Markus Tiemann · 2021 · Journal of Molecular Pathology
- Potential of Circulating Tumor DNA for the Management of Patients With LymphomaSarah Huet, Gilles Salles · 2020 · JCO Oncology Practice
- Cross-reactivity between microbial and tumor antigensZitvogel, Laurence, Kroemer, Guido · 2022 · Current Opinion in Immunology
- Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)Huijuan Chen, Qiming Zhou · 2023 · Oncology Reports
- Liquid biopsy: Cell-free DNA based analysis in breast cancerKonstantinos Venetis, Giulia Cursano, Carlo Pescia, Marianna D’Ercole, Francesca Maria Porta, Marta Cruz Blanco, Chiara Frascarelli, Mariia D. Ivanova, Elena Guerini‐Rocco, Nicola Fusco · 2023 · The Journal of Liquid Biopsy
- Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinomaXiaomin Huang, Pascal H. G. Duijf, Sharath Sriram, Ganganath S. Perera, Sarju S. Vasani, Liz Kenny, Paul Leo, Chamindie Punyadeera · 2023 · Journal of Biomedical Science
- Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integrationChangshu Li, Jun Shao, Peiyi Li, Jiaming Feng, Jingwei Li, Chengdi Wang · 2023 · Cancer Letters
- Diagnostic potential of tumor DNA from ovarian cyst fluidYuxuan Wang, Karin Sundfeldt, Constantina Mateoiu, Ie‐Ming Shih, Robert J. Kurman, Joy Schaefer, Natalie Silliman, Isaac Kinde, Simeon U. Springer, Michael Bonner Foote et al. · 2016 · eLife
- Advancing Ultrasensitive Molecular and Cellular Analysis Methods to Speed and Simplify the Diagnosis of DiseaseShana O. Kelley · 2017 · Accounts of Chemical Research
- Molecular Profiling of Liquid Biopsy Samples for Precision MedicineCamila D. M. Campos, Joshua M. Jackson, Malgorzata Anna Witek, Steven A. Soper · 2018 · The Cancer Journal
- Circulating tumor DNA – Current state of play and future perspectivesGabriele De Rubis, Sabna Rajeev Krishnan, Mary Bebawy · 2018 · Pharmacological Research
- Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational studyGuannan Kang, Kezhong Chen, Fan Yang, Shannon Chuai, Heng Zhao, Kai Zhang, Bingsi Li, Zhihong Zhang, Jun Wang · 2019 · BMC Cancer
- Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patientsSteven W. Mes, Arjen Brink, Erik A. Sistermans, Roy Straver, Cees B.M. Oudejans, Jos B. Poell, Charles René Leemans, Ruud H. Brakenhoff · 2020 · Oral Oncology
- Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumorsJiaping Li, Wei Jiang, Jinwang Wei, Jianwei Zhang, Linbo Cai, Minjie Luo, Zhan Wang, Wending Sun, Shengzhou Wang, Chen Wang et al. · 2020 · Journal of Translational Medicine
- Network approach in liquidomics landscapeSantini, Daniele, Botticelli, Andrea, Galvano, Antonio, Iuliani, Michele, Incorvaia, Lorena, Gristina, Valerio, Taffon, Chiara, Foderaro, Simone, Paccagnella, Elisa, Simonetti, Sonia et al. · 2023 · Journal of Experimental & Clinical Cancer Research
- Innovative technological advancements in laboratory medicine: Predicting the lab of the futureS. Wilson, Shannon Steele, Khosrow Adeli · 2022 · Biotechnology & Biotechnological Equipment
- The current status and trends of DNA extractionXiaojun Ye, Bo Lei · 2023 · BioEssays
- Liquid Biopsy: Current advancements in clinical practice for bladder cancerFelice Crocetto, Ugo Amicuzi, Michele Musone, Marco Magliocchetti, Dario Di Lieto, Simone Tammaro, Antonio Luigi Pastore, Andrea Fuschi, Roberto Falabella, Matteo Ferro et al. · 2025 · The Journal of Liquid Biopsy
- Improved sensitivity of circulating tumor DNA measurement using short PCR ampliconsRikke Fredslund Andersen, Karen‐Lise Garm Spindler, Ivan Brandslund, Anders Kristian Moeller Jakobsen, Niels Pallisgaard · 2014 · Clinica Chimica Acta
- Circulating free DNA in the era of precision oncology: Pre‐ and post‐analytical concernsJunliang Lu, Zhi‐Yong Liang · 2016 · Chronic Diseases and Translational Medicine
- A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne BiomarkersSharon Seiko Hori, Amelie M. Lutz, Ramasamy Paulmurugan, Sanjiv Sam Gambhir · 2017 · Cancer Research
- Synthetic Circulating Cell-free DNA as Quality Control Materials for Somatic Mutation Detection in Liquid Biopsy for CancerRui Zhang, Rongxue Peng, Ziyang Li, Peng Gao, Shiyu Jia, Xin Yang, Jiansheng Ding, Yanxi Han, Jiehong Xie, Jinming Li · 2017 · Clinical Chemistry
- Circulating Tumor DNA Testing Opens New Perspectives in Melanoma ManagementAlessandra Sacco, Laura Forgione, Marianeve Carotenuto, Antonella De Luca, Paolo A. Ascierto, Gerardo Botti, Nicola Normanno · 2020 · Cancers
- Challenges in Using ctDNA to Achieve Early Detection of CancerImran S. Haque, Olivier Elemento · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
- Recent progress of biosensors for the detection of lung cancer markersShanchuan Chen, Minghan Li, Ting Weng, Deqiang Wang, Jia Geng · 2023 · Journal of Materials Chemistry B
- Personalizing Surveillance in Head and Neck CancerGlenn J. Hanna, Nirali M. Patel, Sara G. Tedla, Kristen L. Baugnon, Ashley H. Aiken, Nishant Agrawal · 2023 · American Society of Clinical Oncology Educational Book
- The next steps in next-gen sequencing of cancer genomesDavid Neil Hayes, William Y. Kim · 2015 · Journal of Clinical Investigation
- Prostate cancer epigenetics and its clinical implicationsSrinivasan Yegnasubramanian · 2016 · Asian Journal of Andrology
- Circulating tumor DNA testing in advanced non-small cell lung cancerEverett James Moding, Maximilian Diehn, Heather A. Wakelee · 2018 · Lung Cancer
- Technical considerations for circulating tumor DNA detection in oncologyClaire Franczak, Pierre Filhine-Trésarrieu, Pauline Gilson, Jean‐Louis Merlin, Lewis Au, Alexandre Harlé · 2019 · Expert Review of Molecular Diagnostics
- Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic reviewKlára Červená, Pavel Vodička, Veronika Polakova Vymetalkova · 2019 · Mutation Research/Reviews in Mutation Research
- Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep SequencingNaoyuki Iwahashi, Kazuko Sakai, Tomoko Noguchi, Tamaki Yahata, Hitomi Matsukawa, Saori Toujima, Kazuto Nishio, Kazuhiko Ino · 2019 · Scientific Reports
- Liquid Biopsy in Colorectal Carcinoma: Clinical Applications and ChallengesDrahomír Kolenčík, Stephanie N. Shishido, P. Pitule, Jeremy Mason, James B. Hicks, P. Kuhn · 2020 · Cancers
- Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021Pasquale Pisapia, José Luís Costa, Francesco Pepe, Gianluca Russo, Gianluca Gragnano, Alessandro Russo, Antonino Iaccarino, Diego de Miguel‐Pérez, María José Serrano, Valeria Cecilia Denninghoff et al. · 2021 · Critical Reviews in Oncology/Hematology
- Liquid Biomarkers for Improved Diagnosis and Classification of CNS TumorsSevera Bunda, Jeffrey Zuccato, Mathew Ryan Voisin, Justin Z. Wang, Farshad Nassiri, Vikas S. Patil, Sheila Mansouri, Gelareh Mohammed Zadeh · 2021 · International Journal of Molecular Sciences
- Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluidsWei Gu, Eric Talevich, Elaine D. Hsu, Zhongxia Qi, Anatoly Urisman, Scot Federman, Allan Gopez, Shaun Arevalo, Marc Gottschall, Linda Liao et al. · 2021 · Genome Medicine